4x currency trade info - Forex market info
RSS icon Email icon Home icon
  • Biovail Q2 Profit Rises On Wellbutrin Sales - Update

    Posted on August 5th, 2010 Market Trends No comments

    Biovail Corp. (BVF, BVF.TO), a specialty pharmaceutical company, Thursday reported a rise in second-quarter profit, as revenues increased 23%, driven by higher sales of its antidepressant Wellbutrin.

    Comments are closed.